In a historic medical breakthrough that has put Kenya on the global map of advanced surgical care, Kenyatta National Hospital (KNH) has successfully performed the country’s first-ever Minimally Invasive Esophagectomy (MIE).
The groundbreaking seven-hour procedure was carried out on June 30, 2026, on a 43-year-old patient, Mr. Joshua Wanzala, who was diagnosed with esophageal cancer.
Today, just days after the operation, Mr. Wanzala is walking, healing beautifully, and safely swallowing soft foods, a remarkable recovery that has left doctors and medical experts across the country celebrating.
A Life-Saving Procedure Never Seen Before in Kenya
Mr. Wanzala was facing a deadly diagnosis. Esophageal cancer, which attacks the tube connecting the throat to the stomach, is one of the most lethal cancers in Kenya.
Without urgent intervention, his chances of survival were slim. But instead of subjecting him to traditional open surgery that requires massive cuts across the chest and abdomen, a brilliant team of Kenyan specialists opted for a less invasive, more advanced approach.
During the complex operation, surgeons removed Mr. Wanzala’s entire diseased esophagus, reshaped his stomach into a narrow tube, and pulled it up into his chest to create a brand-new food pipe, all through tiny incisions using high-definition imaging technology and specialized laparoscopic instruments.
This procedure, known as Minimally Invasive Esophagectomy (MIE), represents the global standard of care for esophageal cancer and had never been performed in Kenya before.
A Team of Kenyan Specialists Making History
This world-class procedure was made possible by an incredible, dedicated team of Kenyan specialists working seamlessly across every stage of care. The operation was led by Consultant Cardiothoracic and Vascular Surgeons Dr. Joseph Mutie and Dr. Obed Makori, who were supported by Dr. Praxidice, Dr. Muthoni, and Dr. Yakub.
The anesthesia team was headed by Dr. Billow and Dr. P. Chelagat, while the theater nursing team was led by Mr. Kitema, assisted by Mr. Onyari and Mr. Collins.
Post-operative medical oversight has been provided by Dr. L. Ooko, with compassionate nursing care from Ms. P. Anampiu, Ms. B. Githinji, and Ms. G. Theuri.
Speaking after the successful procedure, lead surgeon Dr. Joseph Mutie described the operation as a game-changer for cancer treatment in Kenya. “This is the first Minimally Invasive Esophagectomy performed in Kenya.
It represents the global standard of care and demonstrates that Kenyan patients can now access world-class esophageal cancer surgery within our country,” said Dr. Mutie.
Why This Breakthrough Matters for Kenyan Patients
The minimally invasive approach offers several significant advantages over traditional open surgery. Patients experience less blood loss, reduced pain, fewer respiratory complications, smaller scars, and faster recovery times.
In Mr. Wanzala’s case, doctors reported minimal blood loss during the operation, and no blood transfusion was required. The patient spent six days in the Critical Care Unit before being transferred to the general ward, where recovery has continued smoothly.
A chest X-ray conducted on the third day after surgery showed no signs of infection or other complications, and doctors have confirmed that Mr. Wanzala is now able to consume small amounts of soft food orally an important sign that the reconstructed digestive system is functioning well.
Senior Director of Clinical Services Dr. Joel Lessan said the success of the operation demonstrates the importance of teamwork across multiple medical specialties.
“This milestone reflects the seamless coordination of surgeons, oncologists, anesthesiologists, nurses and critical care teams working together to deliver the highest standard of patient care,” he said.
The Silent Killer: Esophageal Cancer in Kenya
This breakthrough comes at a critical time. Esophageal cancer is an increasing health problem in Kenya, especially in the Central and Western parts of the country, with over 3,000 cases reported in 2022, making it the fourth most common cancer in Kenya.
According to the National Cancer Institute of Kenya, the country records about 4,300 new cases of esophageal cancer annually, with nearly 4,000 resulting in death, making it the deadliest cancer compared to breast and cervical cancer.
The disease has a fatality rate of 99.3 percent due to late recognition of symptoms by both patients and healthcare workers.
Most esophageal cancers are discovered when they have become locally advanced, and symptoms like difficulty swallowing, chest pain, persistent heartburn, and unexplained weight loss are often ignored until it is too late.
Risk factors include consumption of very hot drinks, tobacco and alcohol use, and traditional fermented beverages.
A Defining Moment for Kenya’s Healthcare Sector
KNH Chief Executive Officer Dr. Richard Lesiyampe described the achievement as a defining moment for both the hospital and Kenya’s healthcare sector. “KNH has demonstrated what is possible when clinical excellence, innovation and teamwork come together.
This historic first reinforces KNH’s position as Kenya’s premier national teaching and referral hospital, reflecting our rapidly growing capacity to deliver complex surgical procedures that meet international standards,” he said.
This landmark achievement follows closely on the heels of another major milestone at KNH, where surgeons successfully removed a massive four-kilogram liver tumor during a complex seven-hour surgery just weeks earlier.
The hospital has also performed Kenya’s first balloon pulmonary valvuloplasty on a premature newborn and conducted 424 minimally invasive surgeries in a six-month period.
Hope for Cancer Patients Across Kenya
For Mr. Joshua Wanzala, the journey is not over, but the hardest part is behind him. Today, he is healing beautifully, progressing step by step on soft foods and fluids.
The hospital has expressed deep gratitude to him for choosing and trusting KNH with this life-changing journey.
For thousands of Kenyans diagnosed with esophageal cancer every year, this breakthrough offers new hope. It means that they no longer have to travel abroad to access world-class treatment.
It means that Kenyan specialists have the skills, the technology, and the determination to save lives right here at home. And it means that Kenya is steadily moving toward becoming a regional hub for advanced medical care.
As Dr. Mutie put it, “Kenyan patients can now access world-class esophageal cancer surgery within our country.” That is not just a medical achievement it is a promise kept to every Kenyan battling this deadly disease.
The hospital remains committed to safe, innovative, evidence-based, and patient-centered healthcare for all Kenyans. This historic first is just the beginning.
0 Comments